Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women

This publication has 56 references indexed in Scilit:

• Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral
  Genetics in Medicine, 2017
• Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
  JNCI: Journal of the National Cancer Institute, 2014
• Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial
  JNCI: Journal of the National Cancer Institute, 2014
• Population-based screening for breast and ovarian cancer risk due toBRCA1andBRCA2
  Proceedings of the National Academy of Sciences, 2014
• Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women
  Journal of Clinical Oncology, 2010
• Next-generation DNA sequencing
  Nature Biotechnology, 2008
• Meta-Analysis of BRCA1 and BRCA2 Penetrance
  Journal of Clinical Oncology, 2007
• BRCA1:185delAG found in the San Luis Valley probably originated in a Jewish founder: Table 1.
  Journal of Medical Genetics, 2005
• The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim
  Human Molecular Genetics, 1998
• Could the 185delAG BRCA1 Mutation Be an Ancient Jewish Mutation?
  1997